CDC Report Finds No Connection Between Thimerosal and Autism

CDC Report Finds No Connection Between Thimerosal and Autism

Publication date: Jun 26, 2025

Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. In a new CDC report, investigators found that there was no connection between thimerosal in vaccines and autism or other neurodevelopmental conditions. These include Afluria (multidose presentation), Flucelvax (multidose presentation), and Fluzone (multidose presentation), all with a 0. 01% concentration of thimerosal. The use of the preservative used in FDA-licensed vaccines has significantly declined and were developed into single-dose containers instead of multidose. Thimerosal and Vaccines. Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.

Concepts Keywords
Anthrax Asd
Fungi Autism
June Cdc
Nejmoa0714347 Containing
Vaccines Early
Exposure
Https
Influenza
June
Mercury
Multidose
Prenatal
Thimerosal
Vaccine
Vaccines

Semantics

Type Source Name
drug DRUGBANK Thimerosal
disease MESH Autism
disease MESH autism spectrum disorder
disease MESH morbidity
disease MESH diphtheria
disease MESH tetanus
disease MESH pertussis
pathway KEGG Pertussis
disease MESH hepatitis
disease MESH measles
pathway KEGG Measles
disease MESH mumps
disease MESH rubella
disease MESH attention deficit hyperactivity disorder
disease MESH neurodevelopmental disorders
disease MESH COVID-19
disease MESH influenza
drug DRUGBANK Nonoxynol-9
pathway KEGG Influenza A

Original Article

(Visited 7 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *